Piramal Pharma shares gain after Canada unit gets zero observations from USFDA with no action indicated
Post Content
Latest News
Scoda Tubes IPO allotment: Steps to check status on NSE, BSE and MUFG Intime India
Post Content
Mphasis shares fall 5% on reports of losing its third-largest client
Post Content
Import duty on edible oil halved — The winners and losers in this move
Post Content
Zydus Life gets tentative USFDA approval for tablets used to treat irritable bowel syndrome
Post Content
Morgan Stanley sees three more OPEC+ hikes driving brent lower
Post Content
Apollo Hospitals is doubling down on its biggest and most profitable unit
Post Content
Dr Reddy’s, OneSource shares decline up to 3% after Delhi HC bans Semaglutide sales in India
Post Content
Nykaa shares fall after HSBC downgrade but bulls cite margin improvement
Post Content
Niva Bupa stock falls 11% after shares worth ₹391 crore change hands
Post Content